cagrilintide semaglutide combination cagrisema phase 3 2025 results Novo Nordisk has officially filed for FDA approval of CagriSema, a powerful new once-weekly injection that combines a GLP-1 receptor agonist with an amylin analogue, setting the stage for the next major Amycretin vs CagriSema: Unimolecular vs
Description
25 The dosing schedule was 1000 g daily for 7 days, then 1000 g once per week for 1 month, then 1 1000 g injection monthly for 6 months
I have been going here for the past 3 years
Plan for 4-8 weeks minimum
I even wobbled up to the shed today with a bit of support and had a "new" b12 injection yesterday
Felt much better since using it but havent lost weight Rated 5 out of 5 Jana Rated 5 out of 5 Aaron Chapman Rated 5 out of 5 Kathryn Doherty gave me so much better endurance for the gym Rated 5 out of 5 CHRISTINA GORDON Quality Product
